BioReference buys Roche's prenatal testing business

2021 06 14 23 12 5436 Test Tube Lab Biomaterials 400

BioReference Laboratories has purchased U.S. Ariosa, Roche's prenatal testing business. U.S. Ariosa offers a noninvasive prenatal screening test called Harmony Prenatal that has been used by more than 1.5 million women.

BioReference offers a similar test, ClariTest Core, through its specialty health division, GenPath, it said; U.S. Ariosa's Harmony Prenatal will round out the company's prenatal screening portfolio.

Page 1 of 7
Next Page